Chapter 25.2
Liver Transplantation: Indications, Contraindications and Results
Gregory T. Everson,
Fernando E. Membreno,
Gregory T. Everson
Search for more papers by this authorFernando E. Membreno
Search for more papers by this authorGregory T. Everson,
Fernando E. Membreno,
Gregory T. Everson
Search for more papers by this authorFernando E. Membreno
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Transplant Patient Data Source (2005). Richmond VA: United Network for Organ Sharing. Retrieved August 8, 2005 from the World Wide Web: http://www.patients.unos.org/data.htm.
- Trotter JF, Wachs M, Everson GT et al. (2002) Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 346, 1074–1082.
- Adam R, McMaster P, O'Grady, JG et al. (2003) Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9, 1231–1243.
- Murray KF, Carithers RL Jr, (2005) AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 41, 1407–1432.
- Plotkin JS, Scott VL, Pinna A et al. (1996) Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 2, 426–430.
- Plotkin JS, Benitez RM, Kuo PC et al. (1998) Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 4, 253–257.
- Lucey MR, Brown KA, Everson GT et al. (1997) Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3, 628–637.
- Grace ND (1997) Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 92, 1081–1091.
- Policy. 3.6 Organ Distribution (2001). Richmond VA: United Network for Organ Sharing. Retrieved November 10, 2001 from the World Wide Web: http://www.unos.org/About/policy_policies03_06.htm.
- Freeman RB Jr, Edwards, EB (2000) Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 6, 543–552.
- Institute of Medicine (1999) Analysis of waiting times. In: Committee on Organ Transplantation. Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington DC: National Academy Press, pp. 57–78.
- Wiesner RH, McDiarmid SV, Kamath PS et al. (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7, 567–580.
- Malinchoc M, Kamath PS, Gordon FD et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864–871.
- Freeman RB, Wiesner RH, Edwards E et al. (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10, 7–15.
- Kamath PS, Wiesner RH, Malinchoc M et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33, 464–470.
- Freeman RB, Rohrer RJ, Katz E et al. (2001) Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 7, 173–178.
- Wiesner R, Edwards E, Freeman R et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91–96.
- Olthoff KM, Brown RS, DelMonico FL et al. (2004) Summary Report of a National Conference: evolving concepts in liver allocation in the MELD/PELD era. Liver Transplantation 10 (Suppl. 2), A6–A22.
- McDiarmid SV, Merion RM, Dykstra DM et al. (2004) Selection of pediatric candidates under the PELD system. Liver Transpl 10, S23–30.
- McDiarmid SV, Anand R, Lindblad AS (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74, 173–181.
- Bourdeaux C, Tri TT, Gras J et al. (2005) PELD score and posttrans-plant outcome in pediatric liver transplantation: a retrospective study of 100 recipients. Transplantation 79, 1273–1276.
- Lee WM (1997) Acute Liver Failure. Cambridge: Cambridge University Press.
- O'Grady, JG (2005) Acute liver failure. Postgrad Med J 81, 148–154.
- Dickson ER, Grambsch PM, Fleming TR et al. (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10, 1–7.
- Liermann Garcia RF, Evangelista Garcia, C, McMaster, P et al. (2001) Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 33, 22–27.
- Lee YM, Kaplan MM (1995) Primary sclerosing cholangitis. N Engl J Med 332, 924–933.
- Dickson ER, Murtaugh PA, Wiesner RH et al. (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103, 1893–1901.
- Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangio-carcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol 32, 1042–1045.
- Goss JA, Shackleton CR, Farmer DG et al. (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225, 472–481; discussion 481–483.
- Loftus EV Jr, Aguilar HI, Sandborn, WJ et al. (1998) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27, 685–690.
- Mendes FD, Lindor KD (2004) Primary sclerosing cholangitis. Clin Liver Dis 8, 195–211.
- Graziadei IW, Wiesner RH, Marotta PJ et al. (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30, 1121–1127.
- Graziadei IW, Wiesner RH, Batts KP et al. (1999) Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29, 1050–1056.
- Czaja AJ (2002) Treatment strategies in autoimmune hepatitis. Clin Liver Dis 6, 799–824.
- Gonzalez-Koch, A, Czaja AJ, Carpenter, HA et al. (2001) Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl, 7 302–310.
- Everson G, Bharadhwaj G, House R et al. (1997) Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg 3, 263–274.
- Beresford TP, Everson GT (2000) Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse — but where are the data? Liver Transpl, 6 777–778.
- Bravata DM, Olkin I, Barnato AE et al. (2001) Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 7, 191–203.
- Veldt BJ, Laine F, Guillygomarch, A et al. (2002) Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 36, 93–98.
- Farges O, Saliba F, Farhamant H et al. (1996) Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 23, 240–248.
- Bathgate AJ, Hynd P, Sommerville D et al. (1999) The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 5, 475–479.
- Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362, 1907–1917.
- El-Serag, HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127, S27–34.
- Wall WJ (2000) Liver transplantation for hepatic and biliary malignancy. Semin Liver Dis 20, 425–436.
- Everson GT (2000) Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 6, S2–10.
- Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334, 693–699.
- Sharma P, Balan V, Hernandez JL et al. (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10, 36–41.
- Yoo HY, Patt CH, Geschwind JF et al. (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21, 4329–4335.
- Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127, S261–267.
- El-Serag HB, Davila, JA (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39, 798–803.
- Katzenstein HM, Krailo MD, Malogolowkin MH et al. (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97, 2006–2012.
- Meyer CG, Penn I, James L (2000) Liver transplantation for cholan-giocarcinoma: results in 207 patients. Transplantation 69, 1633–1637.
- De Vreede I, Steers JL, Burch, PA et al. (2000) Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6, 309–316.
- Lehnert T (1998) Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 66, 1307–1312.
- Sutcliffe R, Maguire D, Ramage J et al. (2004) Management of neuroendocrine liver metastases. Am J Surg 187, 39–46.
- Crawford DH, Fletcher LM, Hubscher SG et al. (2004) Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39, 1655–1662.
- Brandhagen DJ, Alvarez W, Therneau TM et al. (2000) Iron overload in cirrhosis — HFE genotypes and outcome after liver transplantation. Hepatology 31, 456–460.
- Bowlus CL, Willner I, Zern MA et al. (2005) Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol 3, 390–396.
- Putnam CW, Porter KA, Peters RL et al. (1977) Liver replacement for alpha1-antitrypsin deficiency. Surgery 81, 258–261.
- Elzouki AN, Lindgren S, Nilsson S et al. (1997) Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproli-ferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. J Hepatol 26, 1403–1407.
- Acharya J, Westwood NB, Sawyer BM et al. (1995) Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol 55, 315–321.
- Deltenre P, Denninger MH, Hillaire S et al. (2001) Factor V Leiden related Budd-Chiari syndrome. Gut 48, 264–268.
- Bismuth H, Sherlock DJ (1991) Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 214, 581–589.
- Shaked A, Goldstein RM, Klintmalm GB et al. (1992) Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 174, 453–459.
- Molmenti EP, Segev DL, Arepally A et al. (2005) The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 241, 978–981; discussion 982–983.
- Ochs A (2005) Transjugular intrahepatic portosystemic shunt. Dig Dis 23, 56–64.
- Pirenne J, Aerts R, Yoong K et al. (2001) Liver transplantation for polycystic liver disease. Liver Transpl 7, 238–245.
- Everson GT, Taylor MR, Doctor RB (2004) Polycystic disease of the liver. Hepatology 40, 774–782.
- Zetterman RK, Belle SH, Hoofnagle JH et al. (1998) Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation 66, 500–506.
- Herrero JI, Lucena JF, Quiroga J et al. (2003) Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 3, 1407–1412.
- Carey WD, Dumot JA, Pimentel RR et al. (1995) The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 59, 859–864.
- Morris JJ, Hellman CL, Gawey BJ et al. (1995) Case 3–1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 9, 322–332.
- Donovan CL, Marcovitz PA, Punch JD et al. (1996) Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61, 1180–1188.
- Krowka MJ, Cortese DA (1994) Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 105, 1528–1537.
- Schenk P, Schoniger-Hekele, M, Fuhrmann, V et al. (2003) Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125, 1042–1052.
- Abrams GA, Nanda NC, Dubovsky, EV et al. (1998) Use of macroag-gregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 114, 305–310.
- Arguedas MR, Abrams GA, Krowka MJ et al. (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37, 192–197.
- Krowka MJ, Porayko MK, Plevak DJ et al. (1997) Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 72, 44–53.
- Kuo PC, Plotkin JS, Gaine S et al. (1999) Portopulmonary hypertension and the liver transplant candidate. Transplantation 67, 1087–1093.
- Castro M, Krowka MJ, Schroeder DR et al. (1996) Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 71, 543–551.
- Ramsay MA, Simpson BR, Nguyen AT et al. (1997) Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 3, 494–500.
- Plotkin JS, Kuo PC, Rubin LJ et al. (1998) Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 65, 457–459.
- Ramsay MA, Spikes C, East CA et al. (1999) The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology 90, 299–301.
- Mair P, Kaehler CH, Pomaroli A et al. (2001) Orthotopic liver transplantation in a patient with severe portopulmonary hypertension. Acta Anaesthesiol Scand 45, 513–518.
- Chua R, Keogh A, Miyashita M (2005) Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 24, 498–500.
- Makisalo H, Koivusalo A, Vakkuri A et al. (2004) Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl 10, 945–950.
- Prachalias AA, Pozniak A, Taylor, C et al. (2001) Liver transplantation in adults coinfected with HIV. Transplantation 72, 1684–1688.
- Neff GW, Bonham A, Tzakis AG et al. (2003) Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 9, 239–247.
- Stock PG, Roland ME, Carlson L et al. (2003) Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 76, 370–375.
- Roland ME, Stock PG (2003) Review of solid-organ transplantation in HIV-infected patients. Transplantation 75, 425–429.
- Brown RS Jr, Lombardero M, Lake, JR (1996) Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 62, 1788–1793.
- Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35, 1179–1185.
- Davis CL, Gonwa TA, Wilkinson AH (2002) Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 8, 193–211.
- McCauley J, Van Thiel DH, Starzl, TE et al. (1990) Acute and chronic renal failure in liver transplantation. Nephron 55, 121–128.
- Arroyo V, Gines P, Navasa M et al. (1993) Renal failure in cirrhosis and liver transplantation. Transplant Proc 25, 1734–1739.
- Shields PL, Tang H, Neuberger JM et al. (1999) Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 68, 530–535.
- John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 34, 889–895.
- Trotter JF, Bak TE, Wachs ME et al. (2000) Combined liver-pancreas transplantation in a patient with primary sclerosing cholangitis and insulin-dependent diabetes mellitus. Transplantation 70, 1469–1471.
- Nair S, Verma S, Thuluvath PJ (2002) Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 35, 105–109.
- Ehlers SL, Rodrigue JR, Widows MR et al. (2004) Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 10, 412–417.
- Pungpapong S, Manzarbeitia C, Ortiz J et al. (2002) Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 8, 582–587.
- Yerdel MA, Gunson B, Mirza D et al. (2000) Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69, 1873–1881.
- Forman LM, Lewis JD, Berlin JA et al. (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122, 889–896.
- Charlton M, Seaberg E, Wiesner R et al. (1998) Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28, 823–830.
- Forman LM (2003) To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis 7, 615–629.
- Marcos A, Ham JM, Fisher RA et al. (2000) Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 6, 296–301.
- Bak T, Wachs M, Trotter J et al. (2001) Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl 7, 680–686.
- Abecassis M, Adams M, Adams P et al. (2000) Consensus statement on the live organ donor. JAMA 284, 2919–2926.
- American Society of Transplant Surgeons (2000) Position paper on adult-to-adult living donor liver transplantation. Liver Transpl 6, 815–817.
- Schiano TD, Kim-Schluger, L, Gondolesi, G et al. (2001) Adult living donor liver transplantation: the hepatologist's perspective. Hepatology 33, 3–9.
- Wachs ME, Bak TE, Karrer FM et al. (1998) Adult living donor liver transplantation using a right hepatic lobe. Transplantation 66, 1313–1316.
- Abt PL, Mange KC, Olthoff KM et al. (2004) Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4, 1302–1307.
- Trotter JF (2005) Living donor liver transplantation: is the hype over? J Hepatol 42, 20–25.
- Marcos A (2000) Right-lobe living donor liver transplantation. Liver Transpl 6, S59–63.
- Broelsch CE, Malago M, Testa G et al. (2000) Living donor liver transplantation in adults: outcome in Europe. Liver Transpl 6, S64–65.
- Todo S, Furukawa H, Jin MB et al. (2000) Living donor liver transplantation in adults: outcome in Japan. Liver Transpl 6, S66–72.
- Trotter JF, Talamantes M, McClure M et al. (2001) Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl 7, 485–493.
- Trotter JF, Wachs M, Trouillot T et al. (2000) Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 6, 290–295.
- Yeh BM, Breiman RS, Taouli B et al. (2004) Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography — initial experience. Radiology 230, 645–651.
- Cheng YF, Chen CL, Huang TL et al. (1999) Magnetic resonance of the hepatic veins with angular reconstruction: application in living-related liver transplantation. Transplantation 68, 267–271.
- Cheng YF, Chen CL, Huang TL et al. (2001) Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. Transplantation 72, 1527–1533.
- White SA, Al-Mukhtar, A, Lodge, JP et al. (2004) Progress in living donor liver transplantation. Transplant Proc 36, 2720–2726.
- Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7, 651–665, viii.
- Garcia-Retortillo, M, Forns X, Llovet, JM et al. (2004) Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40, 699–707.
- Gaglio PJ, Malireddy S, Levitt BS et al. (2003) Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 9, 1028–1035.
- Rodriguez-Luna, H, Vargas HE, Sharma, P et al. (2004) Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 49, 38–41.
- Van Vlierberghe H, Troisi R, Colle, I et al. (2004) Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 77, 210–214.
- Everson GT, Trotter J, Forman L et al. (2005) Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42, 255–262.
